Medicina Legal, Psiquiatría y Patología
Departamento
Queen's University
Kingston, CanadáPublicaciones en colaboración con investigadores/as de Queen's University (25)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations
Nature genetics, Vol. 55, Núm. 3, pp. 369-376
2022
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Nature, Vol. 604, Núm. 7906, pp. 502-508
2016
2015
-
Cross-national variations in reported discrimination among people treated for major depression worldwide: The ASPEN/INDIGO international study
British Journal of Psychiatry, Vol. 207, Núm. 6, pp. 507-514
2013
-
Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: A cross-sectional survey
The Lancet, Vol. 381, Núm. 9860, pp. 55-62
2011
-
Staging neurodegenerative disorders: Structural, regional, biomarker, and functional progressions
Neurotoxicity Research, Vol. 19, Núm. 2, pp. 211-234
2010
-
Clinical staging in the pathophysiology of psychotic and affective disorders: Facilitation of prognosis and treatment
Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 211-228
-
Epigenetics and biomarkers in the staging of neuropsychiatric disorders
Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 347-366
-
Staging perspectives in neurodevelopmental aspects of neuropsychiatry: Agents, phases and ages at expression
Neurotoxicity Research, Vol. 18, Núm. 3-4, pp. 287-305
2008
-
Affective status in relation to impulsive, motor and motivational symptoms: Personality, development and physical exercise
Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 151-168
-
Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: Executive functions and locus of control
Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 205-225
-
Focusing on symptoms rather than diagnoses in brain dysfunction: Conscious and nonconscious expression in impulsiveness and decision-making
Neurotoxicity Research, Vol. 14, Núm. 1, pp. 1-20
-
Schizopsychotic symptom-profiles and biomarkers: Beacons in diagnostic labyrinths
Neurotoxicity Research, Vol. 14, Núm. 2-3, pp. 79-96
2007
-
Comorbidity implications in brain disease: Neuronal substrates of symptom profiles
Neurotoxicity Research, Vol. 12, Núm. 1, pp. 1-15
-
Comorbidity of substance abuse with other psychiatric disorders
Neurotoxicity Research, Vol. 12, Núm. 1, pp. 17-27
-
Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry
Neurotoxicity Research, Vol. 12, Núm. 1, pp. 29-42
-
Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders
Neurotoxicity Research, Vol. 12, Núm. 1, pp. 43-60
2004
-
Gene-environment interplay in affect and dementia: Emotional modulation of cognitive expression in personal outcomes
Neurotoxicity Research, Vol. 6, Núm. 3, pp. 159-173
-
Gene-environment interplay in alcoholism and other substance abuse disorders: Expressions of heritability and factors influencing vulnerabilities
Neurotoxicity Research, Vol. 6, Núm. 5, pp. 343-361